ArticleMolecular cancer therapeutics2024

FZ-AD005, a Novel DLL3-Targeted Antibody-Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models.

Qingsong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.